Bedaquiline: A Novel Addition to Anti-Tubercular Armamentarium

Journal Title: Journal of Biomedical and Pharmaceutical Research - Year 2013, Vol 2, Issue 2

Abstract

In current scenario of rising trend of resistant tuberculosis (TB) and acquired immunodeficiency syndrome (AIDS) co infection with TB, a novel antitubercular drug is a prime need to effectively decrease the disease burden. In lieu of the fact that no new antitubercular drug has come up in last four decades, bedaquiline (TMC 207), an arylquinoline, seems an attractive option for TB patients because of its tendency to cause earlier and sustained antitubercular action, shorten treatment duration, less chances of resistance and better safety as compared to existing second line drugs. Bedaquiline has recently been approved by USFDA on 28th December, 2012 for treating multi drug resistant TB (MDR-TB) in adults ≥18 years. This review elucidates the available evidence on efficacy and safety of this drug after analyzing preclinical and clinical studies. Searches of pubmed, Cochrane database, Medscape, Google and clinicaltrial.org were made for terms like bedaquiline, TMC207 and MDR-TB.

Authors and Affiliations

Ruchika Nandha*| Assistant Professor, Department of Pharmacology, Dr Harvansh Singh Judge Institute of Dental Sciences, Panjab University, Chandigarh , India, Kamlesh Garg| Assistant Professor, Department of Clinical Research, Jamia Hamdard University, New Delhi, India, Harpal Singh| Consultant, Department of Critical Care, Max Superspeciality hospital, Phase 6, Mohali, India, Annu Maheshwari| Department of Pharmacology, Adesh Institute of Medical Sciences, Bathinda,India-Assistant Professor, Department of Pharmacology, Dr Harvansh Singh Judge Institute of Dental Sciences, Panjab University, Chandigarh , India

Keywords

Related Articles

HISTOPATHOLOGICAL CHANGES IN ADHATODA VASICA TREATED MICE STOMACH AFTER GAMMA-IRRADIATION.

In the present study, Adhatoda vasica extract administered and radiation induced changes in the stomach of Swiss Albino male mice were studied. Animals were divided into four groups: Group I containing normal mice served...

BACTERIOLOGICAL PROFILE OF CHRONIC SUPPURATIVE OTITIS MEDIA IN A TERTIARY CARE CENTRE IN SOUTH INDIA

Background: Chronic suppurative otitis media (CSOM) is a disease of multiple aetiologies and is well known for its persistence despite treatment and may result in permanently disabling and potentially fatal complication...

FORMULATION AND EVALUATION OF FAST DISSOLVING ORAL FILMS OF FLUVASTATIN SODIUM BY USING TASTE MASKING TECHNIQUES

Fluvastatin sodium, a HMG-COA reductase inhibitor has shorter half life (1.2). It undergoes extensive first pass metabolism, frequent dosing is required in case of conventional dosage form. It is an bitter drug so an att...

Drug Utilization Pattern of Anesthetics in a Tertiary care Hospital

Background: Anesthesia means ‘loss of sensation’. Medications that cause anesthesia are called anesthetics. Anesthetics are used during tests and surgical operations to induce sleep, which prevents pain and discomfort an...

In Vitro Cytotoxicity Assessment of Imiquimod Loaded Liposomal Gel Formulation Using Basal Cell Carcinoma Cell Line: Part-II

This study was undertaken to address the efficacy of newly formed Imiquimod loaded liposomal gel formulation. The study evaluated the acute toxic effect of liposomal gel formulation intended to be used in skin cancers li...

Download PDF file
  • EP ID EP1646
  • DOI -
  • Views 384
  • Downloads 29

How To Cite

Ruchika Nandha*, Kamlesh Garg, Harpal Singh, Annu Maheshwari (2013). Bedaquiline: A Novel Addition to Anti-Tubercular Armamentarium. Journal of Biomedical and Pharmaceutical Research, 2(2), 15-20. https://europub.co.uk/articles/-A-1646